PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI

Bibliographic Details
Main Authors: Silvia Marce Torra, Aleix Méndez, Antonella Luciana Sturla, Miriam Ratia, Anna Angona Figueras, Paula Amat, Francisca Ferrer-Marín, Silvia Escribano, Emilia Scalzulli, Montserrat Cortes Sansa, Esther Plensa, Natalia Estrada, Marta Cabezon Marco, Mireia Morgades, Maria Alicia Senin Magan, Juan Carlos Hernandez-Boluda, Eduardo Anguita, Massimo Breccia, Valentín García-Gutiérrez, Blanca Xicoy Cirici, Lurdes Zamora
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d
_version_ 1827331455476301824
author Silvia Marce Torra
Aleix Méndez
Antonella Luciana Sturla
Miriam Ratia
Anna Angona Figueras
Paula Amat
Francisca Ferrer-Marín
Silvia Escribano
Emilia Scalzulli
Montserrat Cortes Sansa
Esther Plensa
Natalia Estrada
Marta Cabezon Marco
Mireia Morgades
Maria Alicia Senin Magan
Juan Carlos Hernandez-Boluda
Eduardo Anguita
Massimo Breccia
Valentín García-Gutiérrez
Blanca Xicoy Cirici
Lurdes Zamora
author_facet Silvia Marce Torra
Aleix Méndez
Antonella Luciana Sturla
Miriam Ratia
Anna Angona Figueras
Paula Amat
Francisca Ferrer-Marín
Silvia Escribano
Emilia Scalzulli
Montserrat Cortes Sansa
Esther Plensa
Natalia Estrada
Marta Cabezon Marco
Mireia Morgades
Maria Alicia Senin Magan
Juan Carlos Hernandez-Boluda
Eduardo Anguita
Massimo Breccia
Valentín García-Gutiérrez
Blanca Xicoy Cirici
Lurdes Zamora
author_sort Silvia Marce Torra
collection DOAJ
first_indexed 2024-03-07T16:36:28Z
format Article
id doaj.art-8dad2001e1af4ba89b7deb1f863173f2
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:36:28Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-8dad2001e1af4ba89b7deb1f863173f22024-03-03T09:43:18ZengWileyHemaSphere2572-92412023-08-017e153219d10.1097/01.HS9.0000974664.15321.9d202308003-01840PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKISilvia Marce Torra0Aleix Méndez1Antonella Luciana Sturla2Miriam Ratia3Anna Angona Figueras4Paula Amat5Francisca Ferrer-Marín6Silvia Escribano7Emilia Scalzulli8Montserrat Cortes Sansa9Esther Plensa10Natalia Estrada11Marta Cabezon Marco12Mireia Morgades13Maria Alicia Senin Magan14Juan Carlos Hernandez-Boluda15Eduardo Anguita16Massimo Breccia17Valentín García-Gutiérrez18Blanca Xicoy Cirici19Lurdes Zamora201 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain2 ICO Hospitalet de Llobregat-Hospital Duran i Reynals, Hematology Department, Hospitalet de Llobregat, Spain2 ICO Hospitalet de Llobregat-Hospital Duran i Reynals, Hematology Department, Hospitalet de Llobregat, Spain3 ICO Girona-Hospital Josep Trueta, Hematology Department, Girona, Spain4 Hospital Clínico Universitario-INCLIVA de Valencia, Hematology Department, Valencia, Spain5 Hospital General Universitario Morales Messeguer-CIBERER, UCAM, Hematology-Oncology Department, Murcia, Spain6 Hospital Clínico San Carlos, IML, IdISSC, Department of Medicine, Universidad Complutense de Madrid (UCM), Hematology Department, Madrid, Spain7 Policlinico Umberto 1, Sapienza University, Hematology, Department of Precision and Translational Medicine, Rome, Italy8 Hospital General de Granollers, Hematology Department, Granollers, Spain9 Consorci Sanitaria del Maresme, Hospital de Mataró, Hematology Department, Mataró, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain2 ICO Hospitalet de Llobregat-Hospital Duran i Reynals, Hematology Department, Hospitalet de Llobregat, Spain4 Hospital Clínico Universitario-INCLIVA de Valencia, Hematology Department, Valencia, Spain6 Hospital Clínico San Carlos, IML, IdISSC, Department of Medicine, Universidad Complutense de Madrid (UCM), Hematology Department, Madrid, Spain7 Policlinico Umberto 1, Sapienza University, Hematology, Department of Precision and Translational Medicine, Rome, Italy10 Hospital Ramón y Cajal, Hematology Department, Madrid, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spain1 ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Instiute (IJC), Hematology Department, Badalona, Spainhttp://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d
spellingShingle Silvia Marce Torra
Aleix Méndez
Antonella Luciana Sturla
Miriam Ratia
Anna Angona Figueras
Paula Amat
Francisca Ferrer-Marín
Silvia Escribano
Emilia Scalzulli
Montserrat Cortes Sansa
Esther Plensa
Natalia Estrada
Marta Cabezon Marco
Mireia Morgades
Maria Alicia Senin Magan
Juan Carlos Hernandez-Boluda
Eduardo Anguita
Massimo Breccia
Valentín García-Gutiérrez
Blanca Xicoy Cirici
Lurdes Zamora
PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
HemaSphere
title PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_full PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_fullStr PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_full_unstemmed PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_short PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
title_sort pb1962 influence of transcript types in sustained deep molecular response sdmr and treatment free remission tfr in chronic phase chronic myeloid leukemia cp cml patients treated with tki
url http://journals.lww.com/10.1097/01.HS9.0000974664.15321.9d
work_keys_str_mv AT silviamarcetorra pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT aleixmendez pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT antonellalucianasturla pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT miriamratia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT annaangonafigueras pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT paulaamat pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT franciscaferrermarin pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT silviaescribano pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT emiliascalzulli pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT montserratcortessansa pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT estherplensa pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT nataliaestrada pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT martacabezonmarco pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT mireiamorgades pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT mariaaliciaseninmagan pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT juancarloshernandezboluda pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT eduardoanguita pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT massimobreccia pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT valentingarciagutierrez pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT blancaxicoycirici pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki
AT lurdeszamora pb1962influenceoftranscripttypesinsustaineddeepmolecularresponsesdmrandtreatmentfreeremissiontfrinchronicphasechronicmyeloidleukemiacpcmlpatientstreatedwithtki